GC3110A(QIV)

· Green Cross Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GC3110A(QIV), covering 2016-11-07 to 2016-11-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children [Phase 3]